Apellis Presents 24-Month P-III (OAKS) Post Hoc Results of Pegcetacoplan for the Treatment of Geographic Atrophy at AAO 2022
October 3, 2022
Apellis Reports P-III (DERBY) and (OAKS) Studies Results of Pegcetacoplan for Geographic Atrophy
August 25, 2022
Apellis Reports the US FDA Acceptance and Priority Review of NDA for Pegcetacoplan to Treat Geographic Atrophy
July 20, 2022
Apellis Expands its 2018 R&D Collaboration with Affilogic to Develop Nanofitins-Based Therapies for Neurological Diseases
June 23, 2022
Apellis Presents 18-Month Results of Pegcetacoplan in P-III (DERBY) and (OAKS) Studies for the Treatment of Geographic Atrophy at...
May 3, 2022
Apellis Reports Results of Pegcetacoplan in P-III (DERBY and OAKS) Studies for Geographic Atrophy (GA)
March 17, 2022
No more records!
Incisive News in 3 Shots.
First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2022 PharmaShots - All Rights Reserved.